C19H22FN3O4
Neat
375.40
Room Temperature
106939-30-4; LEVOFLOXACIN IMPURITY 23; (2S)-6-(4-Ethylpiperazin-1-yl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5(13), 6, 8, 11-tetraene-11-carboxylic acid; (3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic Acid; (3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic Acid(Levofloxacin Impurity); (Levofloxacin IMpurity); Levofloxacin Impurity 40; SCHEMBL9119174; CHEMBL1688948; RKL10127; DB-247032; (-)-(s)-9-fluoro-2, 3-dihydro-3-methyl-10-(4-ethyl-1-piperazinyl)-7-oxo-7h-pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid; 7H-Pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid, 10-(4-ethyl-1-piperazinyl)-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-, (3S)-; 7H-Pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylicacid, 10-(4-ethyl-1-piperazinyl)-9-fluoro-2, 3-dihydro-3-methyl-7-oxo- and (3S)-
(2S)-6-(4-ethylpiperazin-1-yl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5(13), 6, 8 and 11-tetraene-11-carboxylic acid
InChI=1S/C19H22FN3O4/c1-3-21-4-6-22(7-5-21)16-14(20)8-12-15-18(16)27-10-11(2)23(15)9-13(17(12)24)19(25)26/h8-9,11H,3-7,10H2,1-2H3,(H,25,26)/t11-/m0/s1